Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-11

Clinical Trial Update: Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing NPH versus basal-bolus insulin for steroid-induced hyperglycemia; the study was terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NPH (insulin NPH)
  • basal-bolus insulin (basal-bolus insulin regimen)

Snippet

Sponsor: Northwestern University | Conditions: Hyperglycemia Steroid-induced, Insulin Resistance, Diabetes | Phase 4 | Status: TERMINATED | Results posted: 2020-09-11